Overall Status

Completed (17)

Terminated (6)

Recruiting (2)

Withdrawn (2)

Sign in for free

Phase

phase 1 (15)

phase 1/phase 2 (4)

phase 2 (4)

phase 3 (2)

early phase 1 (1)

n/a (1)

Collaborator

Ariad Pharmaceuticals (1)

Chiron Corporation (1)

Daiichi Sankyo, Inc. (1)

Enzon Pharmaceuticals, Inc. (1)

The Methodist Hospital Research Institute (1)

VioQuest Pharmaceuticals (1)

Vion Pharmaceuticals (1)

Study Documents

Intervention Type

drug (26)

biological (3)

procedure (2)

radiation (1)

Funder Type

Industry (20)

Other (7)

Study Type

Interventional (27)

Hematologic Malignancies

Showing NaN - NaN of 27

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hematologic Malignancies Trial in Houston (Busulfan, Fludarabine)

Completed

Hematologic Malignancies

Houston, Texas

UT MD Anderson Cancer Center

Jan 24, 2012

Hematologic Malignancies Trial in Houston (Chemotherapy for hematologic malignancy)

Completed

Hematologic Malignancies

Chemotherapy for hematologic malignancy

Houston, Texas

M.D. Anderson Cancer Center

Jan 20, 2012